(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis
Author:
- 1 January 2007
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 13 (8) , 1162-9
Abstract
To investigate the effect of (-)-epigallocatechin-3-gallate (EGCG) on growth of gastric cancer and its possible mechanism. Heterotopic tumors were induced by subcutaneously injection of SGC-7901 cells in nude mice. Tumor growth was measured by calipers in two dimensions. Tumor angiogenesis was determined with tumor microvessel density (MVD) by immunohistology. Vascular endothelial growth factor (VEGF) protein level and activation of signal transducer and activator of transcription 3 (Stat3) were examined by Western blotting. VEGF mRNA expression was determined by RT-PCR and VEGF release in tumor culture medium by ELISA. VEGF-induced cell proliferation was studied by MTT assay, cell migration by gelatin modified Boyden chamber (Transwell) and in vitro angiogenesis by endothelial tube formation in Matrigel. Intraperitoneal injection of EGCG inhibited the growth of gastric cancer by 60.4%. MVD in tumor tissues treated with EGCG was markedly reduced. EGCG treatment reduced VEGF protein level in vitro and in vivo. Secretion and mRNA expression of VEGF in tumor cells were also suppressed by EGCG in a dose-dependent manner. This inhibitory effect was associated with reduced activation of Stat3, but EGCG treatment did not change the total Stat3 expression. EGCG also inhibited VEGF-induced endothelial cell proliferation, migration and tube formation. EGCG inhibits the growth of gastric cancer by reducing VEGF production and angiogenesis, and is a promising candidate for anti-angiogenic treatment of gastric cancer.Keywords
This publication has 29 references indexed in Scilit:
- Constitutive and inducible expression and regulation of vascular endothelial growth factorCytokine & Growth Factor Reviews, 2004
- Green tea and tea polyphenols in cancer preventionFrontiers in Bioscience-Landmark, 2004
- Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptorsLife Sciences, 2003
- Cancer chemopreventive activity and bioavailability of tea and tea polyphenolsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2003
- Angiogenesis inhibited by drinking teaNature, 1999
- Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterpartsCancer Letters, 1998
- Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins.1997
- Inhibition of Liver Metastasis of Human Gastric Carcinoma by Angiogenesis Inhibitor TNP‐470Japanese Journal of Cancer Research, 1996
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaNew England Journal of Medicine, 1991
- A Case‐Control Study of Gastric Cancer and Diet in Northern Kyushu, JapanJapanese Journal of Cancer Research, 1988